Understanding the Scleral Lenses Market Size is fundamental for any strategic planning, from manufacturing capacity expansion to investment decisions. The market is typically valued by considering the aggregate sales of the lenses themselves, related care solutions, and the specialized fitting instruments and diagnostic equipment necessary for their use. The specialty nature of these lenses, which command a higher per-unit price compared to conventional soft lenses, contributes significantly to the market's overall valuation. Growth in market size is directly correlated with the expansion of clinical indications and the rate of practitioner adoption. For instance, the successful marketing of scleral lenses for non-medical reasons, such as for patients who simply desire better comfort than conventional soft lenses, adds substantially to the total addressable market and thus, the valuation.

The calculation of the market size must also account for the volume of lenses sold globally. The increasing production efficiency, driven by automated and advanced manufacturing techniques, allows companies to meet higher demand while potentially lowering unit costs over time, a factor that could accelerate adoption and further inflate the market size. Furthermore, the recurrent revenue from replacement lenses, which are typically replaced annually or bi-annually, forms a stable and reliable component of the market's total valuation. The shift from entirely manual, trial-and-error fitting to algorithm-assisted, data-driven fitting reduces the cost and time barrier for practitioners, acting as an additional catalyst for volume growth and, consequently, a larger overall market valuation.